This is a Sources Sought Notice for the Baltimore Longitudinal Study of Aging (BLSA) to acquire FDA-approved second-generation tau PET imaging radioligands. The government is seeking information from qualified small businesses capable of supplying 70 doses of the [18F]MK-6240 radioligand per year for three years. Responses should demonstrate technical capability and business size status.
Line Items
Item
Qty
Unit
Est. Unit Price
Est. Total
Category
Tau radioligand doses, Catalog Number [18F]MK-6240 (Base Period)
70
doses
$5,000.00
$350,000.00
Medical
Tau radioligand doses, Catalog Number [18F]MK-6240 (Option Period 1)
70
doses
$5,000.00
$350,000.00
Medical
Tau radioligand doses, Catalog Number [18F]MK-6240 (Option Period 2)
70
doses
$5,000.00
$350,000.00
Medical
Estimated Bid Value
$1,050,000.00
Want the full details?
Sign up free to see the agency name and the original bid posting link, plus contracting-officer contacts and AI response outlines. Every feature is free through December 31, 2026.